Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-CTL for CMV Prevention After Stem Cell Transplant
NCT00986557Phase 2Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- Sep 2009
- Primary completion
- Aug 2013
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of cytomegalovirus-specific cytotoxic T lymphocytes in cytomegalovirus infection (CMV), sponsored by University Hospitals Birmingham. Status: unknown.
02
Drugs
cytomegalovirus-specific cytotoxic T lymphocytes
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00986557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986557.